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Abstract Amphiphysin I and II are nerve terminal-enriched 
proteins thought to function in synaptic vesicle endocytosis. In 
addition to a C-terminal SH3 domain, the proteins contain a 
highly conserved putative SH3 binding site and numerous 
consensus phosphorylation sites. We now demonstrate that 
amphiphysin I but not amphiphysin II is a phosphoprotein which 
undergoes dephosphorylation during nerve terminal depolariza- 
tion. Further, both amphiphysin I and II interact with the SH3 
domain of endophilin, a synaptically enriched protein implicated 
in synaptic vesicle endocytosis. The interaction is direct and 
mediated through a 43 amino acid region of amphiphysin 
containing the putative SH3 binding site. These data further 
support a role for amphiphysin I, II and endophilin in synaptic 
vesicle endocytosis. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Following their exocytosis at the nerve terminal, synaptic 
vesicle membranes are retrieved by an endocytic process 
which utilizes clathrin-coated pits and vesicles [1]. Several lines 
of evidence suggest an important role for the SH3 domain- 
containing protein, amphiphysin I, in synaptic vesicle endocy- 
tosis [2,3]. Amphiphysin I is the mammalian homologue of the 
yeast proteins Rvsl61 and Rvs167 [3], mutations in which 
lead to impaired endocytic function in yeast [4]. Further, am- 
phiphysin I is enriched in nerve t rminals were it binds 
through its SH3 domain to proline-rich sequences in dynamin 
and synaptojanin [5,6]. Dynamin functions in endocytosis by 
mediating the fission of endocytic vesicles [7]. Synaptojanin, 
which has also been implicated in synaptic vesicle endocytosis 
[6], dephosphorylates several inositol polyphosphates and in- 
ositol phospholipids at the 5' position of the inositol ring (5- 
phosphatase) [6,8], although the exact function of this activity 
in endocytosis is unknown. Interestingly, both dynamin and 
synaptojanin are phosphorylated in resting nerve termini but 
become dephosphorylated during nerve terminal depolariza- 
tion [9,10]. In addition to its interactions with dynamin and 
synaptojanin, amphiphysin I binds in an SH3 domain-inde- 
pendent manner to the clathrin assembly protein AP2 
[5,11,12] and to clathrin [12]. Finally, injection of the amphi- 
physin I SH3 domain into the presynaptic side of the lamprey 
giant reticulospinal synapse impairs synaptic vesicle endocy- 
tosis [13]. 
We have recently cloned a novel amphiphysin isoform (am- 
phiphysin II) based on an I.M.A.G.E. Consortium cDNA 
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clone identified through an amphiphysin I homology search 
of the data base of expressed sequence tags [12]. Like amphi- 
physin I, amphiphysin II is enriched in brain, is concentrated 
in the presynaptic nerve terminal, and binds directly to cla- 
thrin [12]. Amphiphysin II also binds through its SH3 domain 
to synaptojanin and dynamin [12]. Sequence comparisons of 
amphiphysin I and II reveal a number of consensus phospho- 
rylation sites for various protein kinases as well as a highly 
conserved consensus SH3 binding site [12,14-16]. However, 
no SH3 domain-containing proteins are known to interact 
with amphiphysin I or II. 
We have also recently identified a large number of SH3 
domain-containing proteins using the COLT (cloning of lig- 
and targets) method with SH3 peptide ligands [17]. Three of 
the proteins isolated (SH3P4, SH3P8, SH3P13) are members 
of a novel protein family and we independently isolated one of 
them (SH3P4) as the major synaptojanin-binding protein in 
the brain [18]. Like amphiphysin I and II, SH3P4 is enriched 
in the brain and is concentrated in soluble fractions from the 
nerve terminal [18]. In this article, we have continued our 
studies on these endocytic proteins and have determined 
that amphiphysin I (but not amphiphysin II or SH3P4) is a 
phosphoprotein which becomes dephosphorylated during 
nerve terminal depolarization. Further, we have demonstrated 
a direct and specific interaction between the SH3 domain of 
SH3P4 and amphiphysin I and II. These data further support 
a role for the amphiphysins and SH3P4 in synaptic vesicle 
endocytosis. Based on its affinity for several endocytic pro- 
teins, we have renamed SH3P4 endophilin. 
2. Materials and methods 
2.1. Antibodies 
Polyclonal anti-endophilin antibodies (1903 and 1904) were made 
against an 18 amino acid peptide (CQPKPRMSLEFATGDSTQ) 
chosen from a region unique to endophilin compared to the two other 
proteins from the same family, SH3P8 and SH3P13 [17]. The peptide 
was synthesized atthe W.M. Keck Biotechnology Resource Labora- 
tory at Yale University, conjugated to KLH (Calbiochem) as de- 
scribed [19] and injected into rabbits (approximately 600 gg per rab- 
bit) using Titermax adjuvant (CytRx Corp) with standard protocols. 
Antibodies were affinity purified from sera against strips of polyvin- 
ylidene difluoride membrane (BioRad) containing the peptide conju- 
gated to BSA as described [20]. A polyclonal antibody against amphi- 
physin II which cross-reacts with amphiphysin I (1874) was previously 
described [12] as were polyclonal antibodies against synaptojanin [10] 
and dynamin [5]. A monoclonal antibody against dynamin (HUDY-1) 
was from UBI. 
2.2. Preparation of ficsion proteins 
Full length endophilin n pEXlox(+) [17] was used to generate GST 
fusion proteins by PCR with Vent DNA Polymerase (New England 
Biolabs) using the following primer pairs: GST/full length endophilin 
(amino acids 1-352), forward primer 5'-GCGGGATCCATGTCGG- 
TGGCAGGGCTG and reverse primer 5'-GCGGAATTCTCAATG- 
GGGCAGAGCAACCAG; GST/N-terminal domain (amino acids 1- 
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291), forward primer 5 ' -GCGGGATCCATGTCGGTGGCAGGGC- 
TG and reverse primer 5'-GCGGAATTCTCACATTTGGACAC- 
CTGGAGG; GST/SH3 domain (amino acids 292-352), forward pri- 
mer 5'-GCGGGATCCGATCAGCCCTGCTGCCG and reverse 
primer 5'-GCGGAATTCTCAATGGGGCAGAGCAACCAG. The 
PCR products were cloned in frame into the BamHI-EcoRI sites of 
pGEX-2TK (Pharmacia) and the resulting GST fusion proteins were 
expressed and purified as described [21]. Full length endophilin was 
also expressed as a histidine tagged fusion protein [(His)~ endophilin] 
by subcloning the PCR product into pTrcHis A (Invitrogen). The 
fusion protein was expressed and purified on Ni-NTA resin (Qiagen) 
as recommended bythe manufacturer. GST fusion proteins from the 
insert domains of amphiphysin 1 (amino acids 291445) and amphi- 
physin I! (amino acids 329444) were prepared as described [12]. For 
the amphiphysin 11 deletion construct, PCR was performed exactly as 
described for the amphiphysin II insert domain fusion protein [12] 
except that the template was a naturally occurring amphiphysin It 
splice form which lacks the first 43 amino acids of the amphiphysin 
II insert domain (amino acids 335 377). GST fusion proteins of the 
SH3 domain of amphiphysin l [3] and amphiphysin II [12] were pre- 
pared as described elsewhere. GST fusion proteins pre-bound to glu- 
tathione-Sepbarose were used in affinity bead assays as described [12]. 
2.3. Phos7~hory&tion assays 
The phosphorylation a d dephosphorylation states of amphiphysin 
1, I1 and endophilin were assessed in rat brain synaptosomes a pre- 
viously described for synaptojanin [10] except these proteins were 
specifically immunoprecipitated from synaptosomal lysates using anti- 
bodies loaded onto protein A-Sepharose. 
3. Results and discussion 
We have recently identified endophilin as a major synapto- 
janin-binding protein in the brain [17,18]. As part of endophi- 
lin's characterization, we generated an affinity purified anti- 
peptide antibody against he protein. A Western blot of crude 
rat brain homogenate with this antibody recognizes a single 
band of 40 kDa (Fig. 1), the predicted molecular weight of 
endophilin [17]. A Western blot with an affinity purified anti- 
body against amphiphysin II detects amphiphysin l (125 kDa) 
and amphiphysin II (90 kDa) (Fig. 1) [12]. 
Two important proteins in synaptic vesicle endocytosis are 
dynamin and synaptojanin. These two proteins share the 
property that they are phosphorylated in a resting nerve ter- 
minal but become rapidly dephosphorylated in response to 
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Fig. 1. Western blots of crude rat brain homogenate reacted with 
affinity purified antibodies against amphiphysin 1 and II and endo- 
philin. The migration of molecular weight markers (kDa) is indi- 
cated on the left. 
nerve terminal depolarization [9,10]. We, therefore, decided 
to test whether amphiphysin I, II, or endophilin also change 
phosphorylation state in response to nerve terminal depolari- 
zation. Rat brain synaptosomes were pre-labeled with a2PO!~-, 
treated with a control or depolarizing buffer, and the various 
proteins were immunoprecipitated and analyzed by Coomas- 
sie blue staining, Western blot, and autoradiography. Consis- 
tent with previous results, dynamin becomes rapidly dephos- 
phorylated with synaptosomal depolarization (Fig. 2) [9,10]. 
In contrast, endophilin is not phosphorylated (Fig. 2). Inter- 
estingly, amphiphysin I is phosphorylated under control con- 
ditions and becomes rapidly dephosphorylated upon depola- 
rization, whereas amphiphysin II does not appear to be 
phosphorylated (Fig. 2) .  The lack of a phosphorylation signal 
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Fig.  2. Rat brain synaptosomes were incubated with a2PO] for 1 h at 37°C and then treated with control buffer (C) or a buffer that causes 
synaptosomal depolarization (D). The synaptosomes were lysed and proteins were immunoprecipitated with antibodies against dynamin, amphi- 
physin I and lI, and endophilin as indicated. Immunoprecipitated samples were resolved by SDS-PAGE and were stained with Coomassie blue 
or were transferred to nitrocellulose and autoradiographed. The same transfers were then Western blotted with antibodies against he proteins 
as indicated (Western). The migratory positions of the proteins (kDa) are indicated with arrows. 
310 K.D. Micheva et al./FEBS Letters 414 (1997) 308-312 
97 
amphiphysin I 
i g  ~1-- amphiphysin II 
~, A\ "~ ,.¢b'~ 
Fig. 3. Left panel: Triton X-100 soluble proteins from rat brain were incubated with a GST fusion protein encoding full length endophilin con- 
jugated to glutathione-Sepharose and material specifically bound to the beads was eluted with SDS-PAGE sample buffer. Aliquots of the crude 
extract (starting material; SM; 100 lag), unbound material (void), and bead fraction (beads) were analyzed by SDS-PAGE. Right panel: Triton 
X-100 soluble proteins were incubated with GST fusion proteins encoding the N-terminal domain of endophilin or the C-terminal SH3 domain 
of endophilin conjugated to glutathione-Sepharose and material specifically bound to the beads was eluted with SDS-PAGE sample buffer. An 
aliquot of the crude extract (starting material; SM; 100 lag)was also run on the gel. Both samples were then processed for Western blotting 
with an antibody against amphiphysin I and II.
for endophilin and amphiphysin II is unlikely due to a sensi- 
tivity problem as both proteins are readily detectable in the 
immunoprecipitates as determined by both Western blots and 
Coomassie blue staining (Fig. 2). Thus, amphiphysin I joins 
synaptojanin and dynamin as nerve terminal proteins under- 
going rapid dephosphorylation coinciding with synaptic 
vesicle mobilization. It has been proposed that SH3 domain- 
independent interactions of amphiphysin with AP2 and cla- 
thrin play a role in targeting synaptojanin and dynamin to 
endocytic sites in the nerve terminal [5,11,12]. It is possible 
that dephosphorylation of synaptojanin, dynamin, and am- 
phiphysin I is one aspect of these targeting events. 
Interactions between SH3 domain-containing proteins and 
proline-rich proteins in the nerve terminal have also been 
implicated in the regulation of the synaptic vesicle cycle [13]. 
In addition to a C-terminal SH3 domain, amphiphysin I and 
II contain a conserved proline-rich sequence which forms a
consensus binding site for SH3 domains [12,14-16]. To date, 
no SH3 domain-containing protein(s) have been identified 
which interact with this sequence. Therefore, we decided to 
investigate if the SH3 domain of endophilin could interact 
with amphiphysin I or II through this proline-rich domain. 
For these experiments, we coupled a GST fusion protein en- 
coding full length endophilin to glutathione-Sepharose and
incubated the beads with protein extracts from rat brain. En- 
dophilin specifically bound both amphiphysin I and II (Fig. 
3). To determine the domain of endophilin ecessary for the 
interaction, we generated two additional GST fusion proteins, 
one encoding the SH3 domain and a second encoding the N- 
terminal of endophilin w thout the SH3 domain. Amphiphys- 
in I and II bind to the SH3 domain of endophilin but not he 
N-terminal domain, demonstrating that the interaction is both 
specific and SH3 domain-dependent (Fig. 3). To further dem- 
onstrate the specificity of the interaction, we generated GST 
fusion proteins encoding the SH3 domains of amphiphysin I 
and II. Amphiphysin I and II bind strongly to the SH3 do- 
main of endophilin, but bind only very weakly to the SH3 
domain of amphiphysin II and not at all to the SH3 domain 
of amphiphysin I (Fig. 4). In contrast, synaptojanin binds 
equally well to all three fusion proteins (Fig. 4). To further 
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Fig. 4. Triton X-100 soluble proteins from rat brain were incubated with GST fusion proteins encoding the SH3 domain of amphiphysin I, am- 
phiphysin II, and endophilin conjugated to glutathione-Sepharose and material specifically bound to the beads was eluted with SDS-PAGE 
sample buffer. The bead fractions and an aliquot of the crude extract (starting material; SM; 100 p.g)were Western blotted with antibodies 
against amphiphysin I a d II (top panel) and an antibody against synaptojanin (bottom panel). 
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Fig. 5. Triton X-100 soluble proteins from rat brain (brain extract; top panels) and purified full length recombinant endophilin [(His)6 endo- 
philin; bottom panels] were incubated with GST fusion proteins encoding the insert domain [12] of amphiphysin I (amphi. I) or amphiphysin 
II (amphi. II), and an amphiphysin II deletion construct lacking the first 43 amino acids of the insert domain (amphi. 1I deletion construct) 
pre-bound to glutathione-Sepharose. Material specifically bound to the beads was eluted with SDS-PAGE sample buffer and analyzed on SDS- 
PAGE along with aliquots of the crude extract or the purified endophilin (starting material: SM; 100/.tg of crude extract, 1 I, tg of purified en- 
dophilin), unbound material (void), and bead fractions (beads). All samples were processed for Western blotting with an anti-endophilin anti- 
body. The migratory positions of endophilin and (His)6 endophilin (kDa) are indicated. 
delineate the amphiphysin/endophilin interaction, we gener- 
ated GST fusion proteins encoding the insert domain of am- 
phiphysin I and II. The insert domain is defined as the central 
regions of amphiphysin I and II which are not present in the 
amphiphysin homologues Bin l and SH3P9 [12,17,22]. We also 
generated a fragment of the amphiphysin II insert domain 
missing a 43 amino acid segment hat includes the sequence 
RKGPPVPPLP  which resembles the consensus for SH3 do- 
main ligands [15,16]. The three fusion proteins were incubated 
with brain extracts and the affinity selected proteins were an- 
alyzed with an anti-endophilin Western blot. Endophilin 
bound to the insert domain of both amphiphysin I and II 
but did not bind to the amphiphysin II deletion construct 
(Fig. 5). Identical results were seen when the amphiphysin 
fusion proteins were incubated with purified recombinant en- 
dophilin (Fig. 5) indicating that the interaction is direct. 
Taken together, the data presented in this study demon- 
strate that amphiphysin I and II have the capacity to interact 
with endophilin. The interaction is direct and is likely medi- 
ated through the proline-rich sequence RKGPPVPPLP  which 
matches a class I SH3 consensus binding sequence [16]. Such 
interactions appear to play a central role in the endocytosis of 
synaptic vesicles [13]. Amphiphysin I and II are both highly 
enriched in the brain and are concentrated in the presynaptic 
nerve terminal [5,12], as is endophilin [18], suggesting that 
these proteins could be important physiological partners. 
We suggest hat such an interaction between endophilin and 
the two amphiphysins may be of a transient, regulatory nature 
as immunoprecipitation experiments of rat brain synapto- 
somes have detected only the interaction of endophilin with 
synaptojanin (Micheva, Kay and McPherson, in preparation). 
We hypothesize that amphiphysin may function in targeting 
dynamin and synaptojanin from the cytosol to sites of endo- 
cytosis on the plasma membrane, that endophilin may regu- 
late the availability of synaptojanin for the targeting complex, 
and that endophilin and amphiphysin may interact only tran- 
siently during a specific step of this cycle of protein interac- 
tions. Regardless, the data presented here provide further sup- 
port of a role for endophilin in synaptic vesicle endocytosis. 
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